C-reactive Protein Testing Market Expected to Grow at 2.9% CAGR, Reaching USD 4 billion by 2031: Transparency Market Research, Inc.

Growing demand for precision medicine and biomarkers will drive C-reactive protein testing market growth.Wilmington, Delaware, United States, Feb. 15, 2024 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. - The C-reactive protein testing market was worth US$ 3.1 billion in 2022. A CAGR of 2.9% is projected from 2023 to 2031, and the market will reach more than US$ 4.0 billion in 2031. Integrating data from diverse sources, such as genetic information, electronic health records, and real-tim

Related Keywords

Canada ,Delaware ,United States ,America ,Nikhil Sawlani ,Asia Pacific ,Goldsite Diagnostics Inc ,Premium Research ,Dxgen Corp ,Laboratory Corporation Of America Holdings Labcorp ,Vazyme Biotech Co ,Laboratory Corporation Of America Holdings ,Roche Ltd ,Agilent Technologies Inc ,Abbott Laboratories ,Optibio Co Ltd ,Biotech Inc ,Transparency Market Research Inc ,Getein Biotech Inc ,Transparency Market Research ,Market Research ,North America ,C Reactive Protein Testing Market ,America Holdings ,Fisher Scientific ,C Reactive Protein ,Premium Research Report ,More Reports ,Diagnostics Market ,Prenatal Testing Market ,Canada Toll Free ,Diagnostic Testing ,Global Market ,Thermo Fisher Scientific ,Healthcare Providers ,Market Growth ,Testing Instruments ,Wilmington ,